Health in Marshall Islands 858 indicators covering health for Marshall Islands. IndicatorLatest Year10-yr change Rank Deaths age 10 to 19 - Current trends maintained 6 2030 unchanged 183rd Ipv vaccine coverage 98 2024 up 3.2% 32nd Tb patients living with hiv receiving art 0 2021 — 141st HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2019 unchanged 1st Treatment success rate for patients treated for MDR-TB 0.0% 2022 down 100.0% 159th New leprosy case detection rate per 1 000 000 population 612.55 2024 down 60.1% 4th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 84.0% 2025 — 106th Leprosy registered prevalence rate per 1 000 000 population 532.65 2024 down 69.1% 3rd Leprosy - Number of new leprosy cases among children 2 2024 down 91.3% 54th Leprosy - Number of cases registered for treatment 20 2024 down 78.0% 75th New leprosy child case detection rate (less than 15 years of age) per 154.5 2024 down 85.3% 5th Ipv1 number unvaccinated 16.86 2023 down 70.1% 184th Age-standardized prevalence of current tobacco use among persons aged 29.9% 2024 up 3.5% 26th Number of female leprosy new cases 11 2024 down 60.7% 63rd National smoking ban: NUMBER OF PLACES SMOKE-FREE 8 2022 unchanged 1st Number of prevalent tuberculosis cases 250 2014 up 8.7% 160th Number of new G2D leprosy cases 0 2024 — 86th Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0 2024 — 86th 3.7.2 Adolescent birth rate per 1,000 women 82 2010 up 0.5% 31st Proportion of total government spending on essential services, health 17.8% 2019 up 37.4% 14th 3.1.2 Proportion of births attended by skilled health personnel 92 2017 up 6.7% 117th Inflation-adjusted prices for most sold brand of cigarettes: Prices 2.26 2022 down 42.2% 167th Taxes as a % of price: total tax 51.1% 2022 up 28.8% 106th Taxes as a % of price: value added tax 3.9% 2022 unchanged 165th Taxes as a % of price: ad valorem excise 0.0% 2022 — 106th Taxes as a % of price: specific excise 0.0% 2022 — 135th Taxes as a % of price: import duties 40.0% 2022 up 40.0% 3rd Taxes as a % of price: other taxes 7.3% 2022 down 0.1% 10th Inflation-adjusted prices for most sold brand of cigarettes: Price in 2.5 2022 down 33.9% 170th Physical activity policies for activie societies 20 2023 up 100.0% 2nd Physical activity policies focused on active systems 10 2023 down 50.0% 101st Share of one year olds who received the final dose of pneumococcal vac 62 2024 up 113.8% 130th Diphtheria tetanus pertussis vaccine vs pneumococcal vaccine coverage 62 2024 up 113.8% 130th 3.8.1 Coverage of essential health services 59 2021 up 3.5% 124th Rotavirus number unvaccinated 472.08 2023 down 26.5% 95th Affordability - percentage of GDP per capita required to purchase 5.15 2022 down 50.2% 69th Japanese encephalitis - number of reported cases 0 2025 — 19th Deaths and missing persons due to natural disasters 42.42 2022 — 9th Hiv expenditure 679,774 2014 up 454.8% 88th Number of new leprosy cases with G2D among children 0 2024 — 35th Most sold brand of cigarettes - price in currency reported 2.5 2020 down 9.1% 177th Most sold brand of cigarettes - taxes as a % of price - total tax 0.5% 2020 up 10.2% 95th Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.0% 2020 — 109th Most sold brand of cigarettes - taxes as a % of price - other taxes 0.1% 2020 up 11.1% 7th Most sold brand of cigarettes - taxes as a % of price - import duties 0.4% 2020 up 11.1% 4th Most sold brand of cigarettes - taxes as a % of price - value added 0.0% 2020 unchanged 158th Most sold brand of cigarettes - taxes as a % of price - specific 0.0% 2020 — 129th Most sold brand of cigarettes - price in US$ at official exchange 2.5 2020 down 9.1% 103rd Most sold brand of cigarettes - price in PPP$ 2.33 2020 down 13.4% 160th Pcv3 number unvaccinated 320.34 2023 down 61.4% 135th Number of non-autochthonous leprosy cases 0 2024 — 47th Population with basic handwashing facilities at home 80.2% 2021 unchanged 41st HPV immunization coverage estimates among primary target cohort (9-14) 70.0% 2025 up 62.8% 60th Tuberculosis - new and relapse cases 139 2011 up 148.2% 160th Coverage of the human papillomavirus vaccine 54 2024 up 285.7% 48th Average of 13 International Health Regulations core capacity scores 56.96 2017 down 22.0% 124th New cases: pulmonary smear-negative 39 2012 up 116.7% 155th Average death rate due to natural disasters 0 2021 — 111th Number of full-time equivalent staff in national agency 3 2022 down 40.0% 64th Total number of notified TB cases 153 2014 up 27.5% 160th ← Previous Page 14 of 15 Next →